Effects of PM2.5 on mucus hypersecretion in airway through miR-133b-5p/EGFR/Claudin1/MUC5AC axis

Lerong Chen1, Liangliang Wu1, Xiaopeng Cheng1

  • 1Department of Respiratory, Jiangxi Provincial Chest Hospital, Nanchang 330006, Jiangxi, China.

Aging
|May 29, 2024
PubMed
Abstract

Insights

Particulate matter (PM2.5) exposure downregulates miR-133b-5p, activating the EGFR/MAPK pathway. This leads to MUC5AC hypersecretion and exacerbates airway inflammation in rats.

Area of Science:

  • Environmental Health
  • Molecular Biology
  • Respiratory Medicine

Background:

  • Particulate matter (PM2.5) is a major air pollutant linked to respiratory diseases.
  • The EGFR/MAPK signaling pathway plays a critical role in airway inflammation and mucus production.
  • MicroRNAs (miRNAs) are emerging as key regulators in various biological processes, including inflammation.

Purpose of the Study:

  • To elucidate the role of the EGFR/MAPK signaling pathway in PM2.5-induced MUC5AC hypersecretion and airway inflammation.
  • To investigate the involvement of miR-133b-5p in this process.

Main Methods:

  • A rat model was established by exposing rats to PM2.5.
  • Interventions included overexpression of miR-133b-5p and Claudin1.
  • Key markers such as IL-1, TNF-α, p-EGFR, MUC5AC, p-ERK1/2, p-JNK, p-p38, and miR-133b-5p were measured using ELISA, HE staining, immunohistochemistry, Western blot, and qPCR.

Main Results:

  • PM2.5 exposure increased serum inflammatory factors (IL-1, TNF-α) and lung tissue damage.
  • miR-133b-5p expression was downregulated, while MUC5AC protein expression was increased in PM2.5-exposed rats.
  • Activation of the EGFR/MAPK pathway (increased p-EGFR, p-ERK1/2, p-JNK, p-p38) and decreased Claudin1 expression were observed.

Conclusions:

  • PM2.5 inhibits miR-133b-5p expression, leading to the activation of the EGFR/MAPK signaling pathway.
  • This activation induces MUC5AC hypersecretion, consequently aggravating PM2.5-related airway inflammation in rats.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
388
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
272
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
286